International Board of Directors 

Breakthrough T1D’s governing body is tasked with accelerating mission progress.

Fiscal Year 2024 Members

  • Grant Beard, Chair
  • Michael Alter
  • Claudia Graham, Ph.D., MPH
  • Joseph (Joe) P. Lacher, Jr.
  • Jeff Plumer
  • Christopher H. Turner
  • Drayton Virkler
  • Karey L. Witty
  • Michelle Griffin, Vice Chair
  • Elizabeth Caswell
  • Karen Jordan
  • Carlton McMillian
  • Jennifer Schneider, M.D.
  • Matt Varey
  • Lisa Wallack
Today, given where the science is, we have an unprecedented opportunity to make a difference in the lives of those living with T1D, here and around the world.” 

Grant Beard

International Board of Directors Chair

Executive Team 

Breakthrough T1D’s executive team partners with our leadership boards to advance our mission.

CEO Aaron J. Kowalski, Ph.D.
Aaron J. Kowalski, Ph.D., speaks at one of Breakthrough T1D’s many events.

Aaron J. Kowalski, Ph.D. 
Breakthrough T1D CEO

Chief Executive Officer Aaron J. Kowalski, Ph.D., drives strategies to advance Breakthrough T1D’s mission to cure, prevent, and treat T1D and its complications. Dr. Kowlaski joined the organization in 2004 and held the position of Chief Mission Officer before assuming his current role as CEO, leading Breakthrough T1D’s research and advocacy strategy. Dr. Kowalski is an internationally recognized scientific expert in T1D research. He has also served as a policy leader for the organization, regularly advising Congress, the U.S. Department of Health and Human Services, and the U.S. Food and Drug Administration. Dr. Kowalski’s scientific expertise, personal experience living with T1D for more than 35 years, and his ability to engage the T1D community enable him to lead Breakthrough T1D in our path to cures

  • Dr. Thomas Danne
    Chief Medical Officer, International
  • Sanjoy Dutta, Ph.D.
    Chief Scientific Officer
  • Rob King
    Chief Financial and Administrative Officer
  • Pam Morrisroe
    Chief Marketing Officer
  • Kathleen Seitz
    Chief Global Development Officer
  • Steven St. Peter, M.D.
    Managing Director, T1D Fund
  • Katie Ellias
    Managing Director, T1D Fund
  • Tracy Mido
    Chief Human Resources Officer
  • Jesse Raben
    Chief Legal and Risk Officer
  • Eric Shen
    Chief of Staff, T1D Fund
  • Lynn Starr
    Chief Global Advocacy Officer
  • Sylvia Tobe
    Managing Director, T1D Fund
  • Sydney Yovic
    Chief Strategy Officer, Chief of Staff
Today, people with T1D are living healthier lives because of the breakthroughs we have championed.”

Aaron J. Kowalski, Ph.D.

Breakthrough T1D CEO

Board of Directors for the T1D Fund: A Breakthrough T1D Venture

The Fund is Breakthrough T1D’s venture investment entity, governed by a distinct board.
  • Tim Clark, Chair
  • Karen Jordan
  • Ellen Leake
  • Jay Eastman
  • Aaron J. Kowalski, Ph.D.
We are at a critical inflection point for type 1 diabetes investment and T1D Fund leadership is steadfast in investing in and accelerating cures that may help this devastating condition.” 

Tim Clark

T1D Fund Board of Directors Chair

Global Mission Board

A group of national volunteer leaders who accelerate Breakthrough T1D’s mission progress through special initiatives.
  • Jennifer Bennett, Chair
  • Randy Anderson
  • Cathy Baier
  • Matthew Cohn
  • Jennie Costner
  • Maarten deGroot
  • Pam Edmonds
  • Ian Joyce
  • Marshall Lang
  • James Lurie, Esq.
  • Mike Norona
  • Carol Oxenreiter
  • Derek Rapp
  • Kim Roosevelt
  • Lorne Schiff
  • Michael Soper
  • Jeff Adams
  • Carmen Ashley
  • Tim Clark
  • Meredith Coors
  • Laura Cramer
  • Nanette DeTurk
  • Cynthia Ford
  • Mark Kacher
  • Mike Lee
  • Gwen Malone
  • Dayton Ogden
  • Margery Perry
  • Lisa Reed
  • Brad Schur
  • David Schwab
  • Jerry Wisler
I can see very tangibly the impact better therapies are making on lives, and that finish line to a cure is getting closer.”

Jennifer Bennett

Global Mission Board Chair